| 1 |
29137116 | Altering Residue 134 Confers an Increased Substrate Range of Alkylated Nucleosides to the E. coli OGT Protein. | 2017 Nov 11 |
1 |
| 2 |
15244247 | A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer. | 2004 |
1 |
| 3 |
11592340 | Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver. | 2001 Sep |
2 |
| 4 |
10096558 | A novel, orally administered nucleoside analogue, OGT 719, inhibits the liver invasive growth of a human colorectal tumor, C170HM2. | 1999 Mar 15 |
1 |